ANI Pharmaceuticals to Present at Raymond James’ Institutional Investors and Leerink Partners Global Healthcare Conferences in March
ANI Pharmaceuticals (ANIP) has announced its participation in two major healthcare investor conferences in March 2025. The company's President and CEO, Nikhil Lalwani, along with senior management members, will present at the Raymond James & Associates' 46th Annual Institutional Investors Conference on March 4 at 1:40 PM ET and the Leerink Partners Global Healthcare Conference on March 11 at 3:40 PM ET.
Both presentations will be available via live and archived webcasts on ANI's website (www.anipharmaceuticals.com) under the Investors section's Events and Presentations area. The webcast replays will remain accessible for 90 days following the events.
ANI Pharmaceuticals (ANIP) ha annunciato la sua partecipazione a due importanti conferenze per investitori nel settore sanitario a marzo 2025. Il Presidente e CEO dell'azienda, Nikhil Lalwani, insieme ai membri senior della direzione, presenterà alla 46ª Conferenza Annuale degli Investitori Istituzionali di Raymond James & Associates il 4 marzo alle 13:40 ET e alla Conferenza Globale sulla Salute di Leerink Partners l'11 marzo alle 15:40 ET.
Entrambe le presentazioni saranno disponibili tramite webcast in diretta e registrati sul sito web di ANI (www.anipharmaceuticals.com) nella sezione Eventi e Presentazioni del settore Investitori. Le registrazioni dei webcast rimarranno accessibili per 90 giorni dopo gli eventi.
ANI Pharmaceuticals (ANIP) ha anunciado su participación en dos importantes conferencias de inversores en el sector de la salud en marzo de 2025. El Presidente y CEO de la empresa, Nikhil Lalwani, junto con miembros de la alta dirección, presentará en la 46ª Conferencia Anual de Inversores Institucionales de Raymond James & Associates el 4 de marzo a la 1:40 PM ET y en la Conferencia Global de Salud de Leerink Partners el 11 de marzo a las 3:40 PM ET.
Ambas presentaciones estarán disponibles a través de webcasts en vivo y grabados en el sitio web de ANI (www.anipharmaceuticals.com) en la sección de Eventos y Presentaciones para Inversores. Las repeticiones de los webcasts estarán accesibles durante 90 días después de los eventos.
ANI Pharmaceuticals (ANIP)는 2025년 3월에 두 개의 주요 헬스케어 투자자 컨퍼런스에 참석할 것이라고 발표했습니다. 회사의 사장 겸 CEO인 Nikhil Lalwani와 고위 경영진이 레이몬드 제임스 & 어소시에이츠 제46회 연례 기관 투자자 회의에서 3월 4일 오후 1시 40분 ET에 발표하며, 리어링크 파트너스 글로벌 헬스케어 컨퍼런스에서는 3월 11일 오후 3시 40분 ET에 발표할 예정입니다.
두 발표 모두 ANI의 웹사이트(www.anipharmaceuticals.com) 투자자 섹션의 이벤트 및 발표 영역에서 실시간 및 아카이브 웹캐스트를 통해 제공될 것입니다. 웹캐스트 재생은 이벤트 종료 후 90일 동안 접근 가능합니다.
ANI Pharmaceuticals (ANIP) a annoncé sa participation à deux grandes conférences d'investisseurs dans le domaine de la santé en mars 2025. Le Président et CEO de l'entreprise, Nikhil Lalwani, ainsi que des membres de la direction, présenteront à la 46ème Conférence Annuelle des Investisseurs Institutionnels de Raymond James & Associates le 4 mars à 13h40 ET et à la Conférence Mondiale sur la Santé de Leerink Partners le 11 mars à 15h40 ET.
Les deux présentations seront disponibles via des webcasts en direct et enregistrés sur le site Web d'ANI (www.anipharmaceuticals.com) dans la section Événements et Présentations des Investisseurs. Les rediffusions des webcasts resteront accessibles pendant 90 jours après les événements.
ANI Pharmaceuticals (ANIP) hat seine Teilnahme an zwei wichtigen Investorenkonferenzen im Gesundheitswesen im März 2025 angekündigt. Der Präsident und CEO des Unternehmens, Nikhil Lalwani, wird zusammen mit Mitgliedern des oberen Managements am 46. jährlichen Konferenz für institutionelle Investoren von Raymond James & Associates am 4. März um 13:40 Uhr ET und an der Leerink Partners Global Healthcare Conference am 11. März um 15:40 Uhr ET teilnehmen.
Beide Präsentationen werden über Live- und Archiv-Webcasts auf der Website von ANI (www.anipharmaceuticals.com) im Bereich Veranstaltungen und Präsentationen der Investoren-Sektion verfügbar sein. Die Wiederholungen der Webcasts sind 90 Tage nach den Veranstaltungen zugänglich.
- None.
- None.
PRINCETON, N.J., Feb. 19, 2025 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (“ANI” or the “Company”) (Nasdaq: ANIP) today announced that Nikhil Lalwani, President and Chief Executive Officer, and select members of senior management, will present at two upcoming investor conferences as follows:
- Raymond James & Associates’ 46th Annual Institutional Investors Conference
Tuesday, March 4, 2025, at 1:40pm ET
- Leerink Partners Global Healthcare Conference
Tuesday, March 11, 2025, at 3:40pm ET
The live and archived webcasts will be accessible from the Company’s website at www.anipharmaceuticals.com, under the Investors section under Events and Presentations. The replay of the webcast will be accessible for 90 days.
About ANI Pharmaceuticals, Inc.
ANI Pharmaceuticals, Inc. (Nasdaq: ANIP) is a diversified biopharmaceutical company committed to its mission of “Serving Patients, Improving Lives" by developing, manufacturing, and commercializing innovative and high-quality therapeutics. The Company is focused on delivering sustainable growth through its Rare Disease business, which markets novel products in the areas of ophthalmology, rheumatology, nephrology, neurology, and pulmonology; its Generics business, which leverages R&D expertise, operational excellence, and U.S.-based manufacturing; and its Established Brands business. For more information, visit www.anipharmaceuticals.com.
Investor Relations:
Lisa M. Wilson, In-Site Communications, Inc.
T: 212-452-2793
E: lwilson@insitecony.com
Source: ANI Pharmaceuticals, Inc.
FAQ
When will ANI Pharmaceuticals (ANIP) present at the Raymond James Conference in March 2025?
What time is ANIP's presentation at the Leerink Partners Conference in March 2025?
How long will ANIP's March 2025 conference webcasts be available for replay?
Where can investors access ANIP's March 2025 conference presentations?
